We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

KKR Affiliate Loans Food Allergy-Focused Biopharma $170M

Law360 (January 4, 2019, 3:31 PM EST) -- An affiliate of private equity giant KKR has agreed to loan Aimmune Therapeutics $170 million to be paid in three separate payments, the food allergy-focused biopharmaceutical company said Friday.

Under the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.